TrueScale Capital

TrueScale Capital is a venture growth firm established in 2020, based in Mumbai and Bengaluru, India. It specializes in investing in the Series B and C stages, focusing on consumer and enterprise technology sectors. The firm is led by Sameer Nath, a co-founder of Iron Pillar, and brings extensive technology investing and growth expertise to its operations. TrueScale Capital partners with established founders who demonstrate significant revenue growth in large target markets, emphasizing capital efficiency. The firm aims to support companies that are digitizing consumption in India and those developing innovative products for global markets, relying on strong relationships with early-stage investors to enhance its investment strategy.
https://crunchbase.com/organization/***
https://linkedin.com/company/***

Sameer Nath

Co-Founder and Managing Partner

2 past transactions

ApnaKlub

Series A in 2023
ApnaKlub is a company focused on transforming the fast-moving consumer goods (FMCG) procurement market by creating a digital platform that connects buyers and brands. The platform aims to streamline the procurement process, providing users with supply consistency, improved profit margins, and access to a wide range of brands. By organizing and digitizing this market, ApnaKlub enables wholesale businesses to enhance their operations and drive revenue growth effectively.

Axio Biosolutions

Series B in 2021
Axio Biosolutions Private Limited is a medical technology company based in Ahmedabad, India, specializing in the development and commercialization of advanced surgical and wound care products. Established in 2007, the company focuses on creating innovative solutions for wound dressings, particularly in pre-hospital emergency care and surgical applications. Its flagship product, AXIOSTAT, is a sterile, non-absorbable haemostatic dressing designed to control bleeding in various traumatic injuries, such as combat and road accidents, as well as surgical procedures. AXIOSTAT is notable for being the first Indian product to receive USFDA clearance for wound care and hemostatic applications. The company primarily serves hospitals, trauma care services, emergency responders, law enforcement, military, and sports officials, addressing the critical need to manage life-threatening bleeding.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.